Mary Anne Dooley

Mary Anne Dooley

UNVERIFIED PROFILE

Are you Mary Anne Dooley?   Register this Author

Register author
Mary Anne Dooley

Mary Anne Dooley

Publications by authors named "Mary Anne Dooley"

Are you Mary Anne Dooley?   Register this Author

59Publications

1599Reads

27Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney.

Clin Immunol 2016 07 18;168:16-24. Epub 2016 Apr 18.

Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2016.04.005DOI Listing
July 2016

Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.

Arthritis Res Ther 2015 Apr 28;17:110. Epub 2015 Apr 28.

Division of Nephrology, Department of Medicine, University of North Carolina (UNC) Kidney Center, 7024 Burnett-Womack Building, Campus Box # 7155, Chapel Hill, NC, 27599-7155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0621-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411763PMC
April 2015

Systemic lupus erythematosus.

Rheum Dis Clin North Am 2014 Aug 3;40(3):xiii-xiv. Epub 2014 Jun 3.

Division of Rheumatology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2014.05.004DOI Listing
August 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.

Pharmacotherapy 2014 Feb 6;34(2):114-22. Epub 2013 Sep 6.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado; Division of Nephrology and Hypertension, UNC Kidney Center, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945423PMC
February 2014

Impact of severe hypothyroidism on cyclophosphamide disposition and routes of metabolism and transport in a patient with treatment-resistant lupus nephritis.

Ann Pharmacother 2013 Jul-Aug;47(7-8):e35. Epub 2013 Jun 4.

School of Medicine, Division of Nephrology and Hypertension, University of North Carolina, UNC Kidney Center, Chapel Hill, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1S012DOI Listing
January 2014

Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation.

Rheum Dis Clin North Am 2010 Feb;36(1):99-108, viii

Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of North Carolina at Chapel Hill, CB #7570, 4001 Old Clinic Building, Chapel Hill, NC 27599-7570, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2009.12.010DOI Listing
February 2010

Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.

Clin J Am Soc Nephrol 2009 Dec 9;4(12):1962-7. Epub 2009 Oct 9.

Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.00490109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798882PMC
December 2009

Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.

Pharmacotherapy 2009 Jan;29(1):7-16

University of North Carolina Kidney Center, Chapel Hill, North Carolina 27599-7155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.29.1.7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901907PMC
January 2009

Therapy Insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease.

Nat Clin Pract Rheumatol 2008 May 25;4(5):250-7. Epub 2008 Mar 25.

Division of Rheumatology and Immunology, University of North Carolina, 3330 Thurston Building, CB#7280, Chapel Hill, NC 27599-7280, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncprheum0770
Publisher Site
http://dx.doi.org/10.1038/ncprheum0770DOI Listing
May 2008

A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.

Clin Immunol 2008 Feb;126(2):189-201

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2007.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812414PMC
February 2008

Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.

J Rheumatol 2007 Oct 15;34(10):2028-34. Epub 2007 Sep 15.

Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798120PMC
October 2007

Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus.

Arthritis Rheum 2007 Aug;57(6):993-9

US Environmental Protection Agency, Washington, DC 20460, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.22894DOI Listing
August 2007

Epidemiology and health services: year in review.

Authors:
Mary Anne Dooley

Curr Opin Rheumatol 2007 Mar;19(2):118-21

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e328040c01dDOI Listing
March 2007

Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss.

J Clin Immunol 2007 Jan 29;27(1):53-68. Epub 2006 Dec 29.

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10875-006-9051-1DOI Listing
January 2007

Human clinical trials in lupus nephritis.

Semin Nephrol 2007 Jan;27(1):115-27

Department of Medicine, Division of Rheumatology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semnephrol.2006.09.011DOI Listing
January 2007

Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.

Rheum Dis Clin North Am 2006 Feb;32(1):91-102, ix

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2005.11.003DOI Listing
February 2006

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

N Engl J Med 2005 Nov;353(21):2219-28

Division of Rheumatology, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa043731DOI Listing
November 2005

Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.

Arthritis Rheum 2005 Oct;53(5):732-9

University of North Carolina at Chapel Hill, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21446DOI Listing
October 2005

Occupational risk factors for the development of systemic lupus erythematosus.

J Rheumatol 2004 Oct;31(10):1928-33

Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
October 2004

Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus.

J Rheumatol 2004 Sep;31(9):1756-62

Medical Research Service, Ralph H. Johnson Veterans Administration Medical Center and Medical University of South Carolina, Charleston, South Carolina, USA.

View Article

Download full-text PDF

Source
September 2004

N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.

J Rheumatol 2004 Jan;31(1):76-80

Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
January 2004

Renal transplantation in children with lupus nephritis.

Am J Kidney Dis 2003 Feb;41(2):455-63

Divisions of Nephrology and Hypertension and Rheumatology, University of North Carolina-Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/ajkd.2003.50056DOI Listing
February 2003

Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history.

J Clin Epidemiol 2002 Oct;55(10):982-9

Epidemiology Branch A3-05, National Institute of Environmental Health Sciences, PO Box 12233, Durham, NC 27709, USA.

View Article

Download full-text PDF

Source
October 2002

Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.

Arthritis Rheum 2002 Jul;46(7):1830-9

Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10365DOI Listing
July 2002

Effects of an osteoporosis prevention program incorporating tailored educational materials.

Am J Health Promot 2002 Jan-Feb;16(3):146-56

School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California 95211, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4278/0890-1171-16.3.146
Publisher Site
http://dx.doi.org/10.4278/0890-1171-16.3.146DOI Listing
February 2002